Tivic Health Systems, Inc. (TIVC) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
47685 Lakeview Blvd.
Fremont, CA 94538
United States of America (the)
Phone
888 276 6888
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
52
First IPO Date
November 11, 2021
| Name | Title | Pay | Year Born |
| Michael Kevin Handley | CEO & Director | 293,922 | 1972 |
| Jennifer Ernst | Co-Founder, Chief Executive Officer & Director | 317,456 | 1968 |
| Lisa G. Wolf | Chief Financial Officer and Principal Financial & Principal Accounting Officer | 333,978 | 1964 |
Tivic Health Systems, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company’s pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offers CDMO services. The company was incorporated in 2016 and is based in San Antonio, Texas.